{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:35:21Z","timestamp":1791250521569,"version":"4.1.0"},"reference-count":124,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2012,10,9]],"date-time":"2012-10-09T00:00:00Z","timestamp":1349740800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1038\/nrrheum.2012.166","type":"journal-article","created":{"date-parts":[[2012,10,9]],"date-time":"2012-10-09T09:06:11Z","timestamp":1349773571000},"page":"645-655","source":"Crossref","is-referenced-by-count":125,"title":["The multiple facets of glucocorticoid action in rheumatoid arthritis"],"prefix":"10.1038","volume":"8","author":[{"given":"Ulrike","family":"Baschant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy E.","family":"Lane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Tuckermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,10,9]]},"reference":[{"key":"BFnrrheum2012166_CR1","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1177\/014107689809101004","volume":"91","author":"J Glyn","year":"1998","unstructured":"Glyn, J. The discovery and early use of cortisone. J. R. Soc. Med. 91, 513\u2013517 (1998).","journal-title":"J. R. Soc. Med."},{"key":"BFnrrheum2012166_CR2","unstructured":"The Nobel Prize in Physiology or Medicine 1950. Nobelprize.org \n                    [online]\n                    \n                   (2012)."},{"key":"BFnrrheum2012166_CR3","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0140-6736(08)60114-2","volume":"371","author":"JW Bijlsma","year":"2008","unstructured":"Bijlsma, J. W. & Jacobs, J. W. Glucocorticoid chronotherapy in rheumatoid arthritis. Lancet 371, 183\u2013184 (2008).","journal-title":"Lancet"},{"key":"BFnrrheum2012166_CR4","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1097\/BOR.0b013e3280d6471a","volume":"19","author":"J Kirwan","year":"2007","unstructured":"Kirwan, J. & Power, L. Glucocorticoids: action and new therapeutic insights in rheumatoid arthritis. Curr. Opin. Rheumatol. 19, 233\u2013237 (2007).","journal-title":"Curr. Opin. Rheumatol."},{"key":"BFnrrheum2012166_CR5","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/nrrheum.2010.179","volume":"6","author":"JN Hoes","year":"2010","unstructured":"Hoes, J. N., Jacobs, J. W., Buttgereit, F. & Bijlsma, J. W. Current view of glucocorticoid co-therapy with DMARDs in rheumatoid arthritis. Nat. Rev. Rheumatol. 6, 693\u2013702 (2010).","journal-title":"Nat. Rev. Rheumatol."},{"key":"BFnrrheum2012166_CR6","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/j.1749-6632.2009.05342.x","volume":"1193","author":"JW Bijlsma","year":"2010","unstructured":"Bijlsma, J. W.  et al. Low-dose glucocorticoid therapy in rheumatoid arthritis: an obligatory therapy. Ann. NY Acad. Sci. 1193, 123\u2013126 (2010).","journal-title":"Ann. NY Acad. Sci."},{"key":"BFnrrheum2012166_CR7","doi-asserted-by":"publisher","first-page":"3371","DOI":"10.1002\/art.21421","volume":"52","author":"S Wassenberg","year":"2005","unstructured":"Wassenberg, S., Rau, R., Steinfeld, P. & Zeidler, H. Very low-dose prednisolone in early rheumatoid arthritis retards radiographic progression over two years: a multicenter, double-blind, placebo-controlled trial. Arthritis Rheum. 52, 3371\u20133380 (2005).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2012166_CR8","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1056\/NEJM199507203330302","volume":"333","author":"JR Kirwan","year":"1995","unstructured":"Kirwan, J. R. The effect of glucocorticoids on joint destruction in rheumatoid arthritis. The Arthritis and Rheumatism Council Low-Dose Glucocorticoid Study Group. N. Engl. J. Med. 333, 142\u2013146 (1995).","journal-title":"N. Engl. J. Med."},{"key":"BFnrrheum2012166_CR9","doi-asserted-by":"publisher","first-page":"3360","DOI":"10.1002\/art.21298","volume":"52","author":"B Svensson","year":"2005","unstructured":"Svensson, B.  et al. Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate: a two-year randomized trial. Arthritis Rheum. 52, 3360\u20133370 (2005).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2012166_CR10","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1359\/JBMR.041125","volume":"20","author":"FN Ton","year":"2005","unstructured":"Ton, F. N., Gunawardene, S. C., Lee, H. & Neer, R. M. Effects of low-dose prednisone on bone metabolism. J. Bone Miner. Res. 20, 464\u2013470 (2005).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrrheum2012166_CR11","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1359\/jbmr.2000.15.6.993","volume":"15","author":"TP Van Staa","year":"2000","unstructured":"Van Staa, T. P., Leufkens, H. G., Abenhaim, L., Zhang, B. & Cooper, C. Use of oral corticosteroids and risk of fractures. J. Bone Miner. Res. 15, 993\u20131000 (2000).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrrheum2012166_CR12","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1002\/art.21796","volume":"54","author":"ML Hetland","year":"2006","unstructured":"Hetland, M. L.  et al. Combination treatment with methotrexate, cyclosporine, and intra-articular betamethasone compared with methotrexate and intra-articular betamethasone in early active rheumatoid arthritis: an investigator-initiated, multicenter, randomized, double-blind, parallel-group, placebo-controlled study. Arthritis Rheum. 54, 1401\u20131409 (2006).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2012166_CR13","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.1073\/pnas.86.7.2374","volume":"86","author":"EM Sternberg","year":"1989","unstructured":"Sternberg, E. M.  et al. Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats. Proc. Natl Acad. Sci. USA 86, 2374\u20132378 (1989).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrrheum2012166_CR14","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1093\/rheumatology\/keh644","volume":"44","author":"DS Jessop","year":"2005","unstructured":"Jessop, D. S. & Harbuz, M. S. A defect in cortisol production in rheumatoid arthritis: why are we still looking? Rheumatology (Oxford) 44, 1097\u20131100 (2005).","journal-title":"Rheumatology (Oxford)"},{"key":"BFnrrheum2012166_CR15","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1210\/en.2011-1398","volume":"153","author":"AE Coutinho","year":"2012","unstructured":"Coutinho, A. E.  et al. 11\u03b2-hydroxysteroid dehydrogenase type 1, but not type 2, deficiency worsens acute inflammation and experimental arthritis in mice. Endocrinology 153, 234\u2013240 (2012).","journal-title":"Endocrinology"},{"key":"BFnrrheum2012166_CR16","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1002\/art.24619","volume":"60","author":"F Buttgereit","year":"2009","unstructured":"Buttgereit, F.  et al. Transgenic disruption of glucocorticoid signaling in mature osteoblasts and osteocytes attenuates K\/BxN mouse serum-induced arthritis in vivo. Arthritis Rheum. 60, 1998\u20132007 (2009).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2012166_CR17","doi-asserted-by":"publisher","first-page":"19317","DOI":"10.1073\/pnas.1105857108","volume":"108","author":"U Baschant","year":"2011","unstructured":"Baschant, U.  et al. Glucocorticoid therapy of antigen-induced arthritis depends on the dimerized glucocorticoid receptor in T cells. Proc. Natl Acad. Sci. USA 108, 19317\u201319322 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrrheum2012166_CR18","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.mce.2007.05.019","volume":"275","author":"C Stahn","year":"2007","unstructured":"Stahn, C., L\u00f6wenberg, M., Hommes, D. W. & Buttgereit, F. Molecular mechanisms of glucocorticoid action and selective glucocorticoid receptor agonists. Mol. Cell Endocrinol. 275, 71\u201378 (2007).","journal-title":"Mol. Cell Endocrinol."},{"key":"BFnrrheum2012166_CR19","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/0092-8674(95)90201-5","volume":"83","author":"M Beato","year":"1995","unstructured":"Beato, M., Herrlich, P. & Sch\u00fctz, G. Steroid hormone receptors: many actors in search of a plot. Cell 83, 851\u2013857 (1995).","journal-title":"Cell"},{"key":"BFnrrheum2012166_CR20","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/352497a0","volume":"352","author":"BF Luisi","year":"1991","unstructured":"Luisi, B. F.  et al. Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA. Nature 352, 497\u2013505 (1991).","journal-title":"Nature"},{"key":"BFnrrheum2012166_CR21","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/ng.759","volume":"43","author":"S John","year":"2011","unstructured":"John, S.  et al. Chromatin accessibility pre-determines glucocorticoid receptor binding patterns. Nat. Genet. 43, 264\u2013268 (2011).","journal-title":"Nat. Genet."},{"key":"BFnrrheum2012166_CR22","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.molcel.2011.06.016","volume":"43","author":"SC Biddie","year":"2011","unstructured":"Biddie, S. C.  et al. Transcription factor AP1 potentiates chromatin accessibility and glucocorticoid receptor binding. Mol. Cell 43, 145\u2013155 (2011).","journal-title":"Mol. Cell"},{"key":"BFnrrheum2012166_CR23","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1038\/emboj.2011.65","volume":"30","author":"R Siersb\u00e6k","year":"2011","unstructured":"Siersb\u00e6k, R.  et al. Extensive chromatin remodelling and establishment of transcription factor 'hotspots' during early adipogenesis. EMBO J. 30, 1459\u20131472 (2011).","journal-title":"EMBO J."},{"key":"BFnrrheum2012166_CR24","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/nature10700","volume":"480","author":"KA Lamia","year":"2011","unstructured":"Lamia, K. A.  et al. Cryptochromes mediate rhythmic repression of the glucocorticoid receptor. Nature 480, 552\u2013556 (2011).","journal-title":"Nature"},{"key":"BFnrrheum2012166_CR25","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.tem.2011.03.009","volume":"22","author":"IM Beck","year":"2011","unstructured":"Beck, I. M., De Bosscher, K. & Haegeman, G. Glucocorticoid receptor mutants: man-made tools for functional research. Trends Endocrinol. Metab. 22, 295\u2013310 (2011).","journal-title":"Trends Endocrinol. Metab."},{"key":"BFnrrheum2012166_CR26","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1101\/gad.1424806","volume":"20","author":"MG Rosenfeld","year":"2006","unstructured":"Rosenfeld, M. G., Lunyak, V. V. & Glass, C. K. Sensors and signals: a coactivator\/corepressor\/epigenetic code for integrating signal-dependent programs of transcriptional response. Genes Dev. 20, 1405\u20131428 (2006).","journal-title":"Genes Dev."},{"key":"BFnrrheum2012166_CR27","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.cell.2011.03.027","volume":"145","author":"M Surjit","year":"2011","unstructured":"Surjit, M.  et al. Widespread negative response elements mediate direct repression by agonist-liganded glucocorticoid receptor. Cell 145, 224\u2013241 (2011).","journal-title":"Cell"},{"key":"BFnrrheum2012166_CR28","first-page":"279","volume":"40","author":"A Dostert","year":"2002","unstructured":"Dostert, A. & Heinzel, T. DNA-dependent cofactor selectivity of the glucocorticoid receptor. Ernst Schering Res. Found Workshop 40, 279\u2013295 (2002).","journal-title":"Ernst Schering Res. Found Workshop"},{"key":"BFnrrheum2012166_CR29","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1126\/science.1164265","volume":"324","author":"SH Meijsing","year":"2009","unstructured":"Meijsing, S. H.  et al. DNA binding site sequence directs glucocorticoid receptor structure and activity. Science 324, 407\u2013410 (2009).","journal-title":"Science"},{"key":"BFnrrheum2012166_CR30","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jsbmb.2010.03.058","volume":"120","author":"U Baschant","year":"2010","unstructured":"Baschant, U. & Tuckermann, J. The role of the glucocorticoid receptor in inflammation and immunity. J. Steroid Biochem. Mol. Biol. 120, 69\u201375 (2010).","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"BFnrrheum2012166_CR31","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1101\/gr.118042.110","volume":"21","author":"NA Rao","year":"2011","unstructured":"Rao, N. A.  et al. Coactivation of GR and NFKB alters the repertoire of their binding sites and target genes. Genome Res. 21, 1404\u20131416 (2011).","journal-title":"Genome Res."},{"key":"BFnrrheum2012166_CR32","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1101\/gad.1297105","volume":"19","author":"HF Luecke","year":"2005","unstructured":"Luecke, H. F. & Yamamoto, K. R. The glucocorticoid receptor blocks P-TEFb recruitment by NF\u03baB to effect promoter-specific transcriptional repression. Genes Dev. 19, 1116\u20131127 (2005).","journal-title":"Genes Dev."},{"key":"BFnrrheum2012166_CR33","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1111\/j.1600-0625.2006.00453.x","volume":"15","author":"H Sch\u00e4cke","year":"2006","unstructured":"Sch\u00e4cke, H., Rehwinkel, H., Asadullah, K. & Cato, A. C. Insight into the molecular mechanisms of glucocorticoid receptor action promotes identification of novel ligands with an improved therapeutic index. Exp. Dermatol. 15, 565\u2013573 (2006).","journal-title":"Exp. Dermatol."},{"key":"BFnrrheum2012166_CR34","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1517\/13543784.14.12.1527","volume":"14","author":"JN Miner","year":"2005","unstructured":"Miner, J. N., Hong, M. H. & Negro-Vilar, A. New and improved glucocorticoid receptor ligands. Expert Opin. Investig. Drugs 14, 1527\u20131545 (2005).","journal-title":"Expert Opin. Investig. Drugs"},{"key":"BFnrrheum2012166_CR35","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1210\/me.2002-0355","volume":"17","author":"MJ Coghlan","year":"2003","unstructured":"Coghlan, M. J.  et al. A novel antiinflammatory maintains glucocorticoid efficacy with reduced side effects. Mol. Endocrinol. 17, 860\u2013869 (2003).","journal-title":"Mol. Endocrinol."},{"key":"BFnrrheum2012166_CR36","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1073\/pnas.0300372101","volume":"101","author":"H Sch\u00e4cke","year":"2004","unstructured":"Sch\u00e4cke, H.  et al. Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects. Proc. Natl Acad. Sci. USA 101, 227\u2013232 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrrheum2012166_CR37","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.coph.2010.04.007","volume":"10","author":"K De Bosscher","year":"2010","unstructured":"De Bosscher, K., Haegeman, G. & Elewaut, D. Targeting inflammation using selective glucocorticoid receptor modulators. Curr. Opin. Pharmacol. 10, 497\u2013504 (2010).","journal-title":"Curr. Opin. Pharmacol."},{"key":"BFnrrheum2012166_CR38","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.4049\/jimmunol.166.3.1975","volume":"166","author":"MG Belvisi","year":"2001","unstructured":"Belvisi, M. G.  et al. Therapeutic benefit of a dissociated glucocorticoid and the relevance of in vitro separation of transrepression from transactivation activity. J. Immunol. 166, 1975\u20131982 (2001).","journal-title":"J. Immunol."},{"key":"BFnrrheum2012166_CR39","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1111\/j.1476-5381.2009.00238.x","volume":"158","author":"H Sch\u00e4cke","year":"2009","unstructured":"Sch\u00e4cke, H.  et al. Characterization of ZK 245186, a novel, selective glucocorticoid receptor agonist for the topical treatment of inflammatory skin diseases. Br. J. Pharmacol. 158, 1088\u20131103 (2009).","journal-title":"Br. J. Pharmacol."},{"key":"BFnrrheum2012166_CR40","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.pharmthera.2011.12.004","volume":"134","author":"AR Clark","year":"2012","unstructured":"Clark, A. R. & Belvisi, M. G. Maps and legends: the quest for dissociated ligands of the glucocorticoid receptor. Pharmacol. Ther. 134, 54\u201367 (2012).","journal-title":"Pharmacol. Ther."},{"key":"BFnrrheum2012166_CR41","doi-asserted-by":"publisher","first-page":"19244","DOI":"10.1073\/pnas.0705517104","volume":"104","author":"JN Miner","year":"2007","unstructured":"Miner, J. N.  et al. Antiinflammatory glucocorticoid receptor ligand with reduced side effects exhibits an altered protein-protein interaction profile. Proc. Natl Acad. Sci. USA 104, 19244\u201319249 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrrheum2012166_CR42","doi-asserted-by":"publisher","first-page":"3123","DOI":"10.1210\/en.2010-1447","volume":"152","author":"X Hu","year":"2011","unstructured":"Hu, X.  et al. The antagonists but not partial agonists of glucocorticoid receptor ligands show substantial side effect dissociation. Endocrinology 152, 3123\u20133134 (2011).","journal-title":"Endocrinology"},{"key":"BFnrrheum2012166_CR43","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/S0092-8674(00)81183-6","volume":"93","author":"HM Reichardt","year":"1998","unstructured":"Reichardt, H. M.  et al. DNA binding of the glucocorticoid receptor is not essential for survival. Cell 93, 531\u2013541 (1998).","journal-title":"Cell"},{"key":"BFnrrheum2012166_CR44","doi-asserted-by":"publisher","first-page":"7168","DOI":"10.1093\/emboj\/20.24.7168","volume":"20","author":"HM Reichardt","year":"2001","unstructured":"Reichardt, H. M.  et al. Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor. EMBO J. 20, 7168\u20137173 (2001).","journal-title":"EMBO J."},{"key":"BFnrrheum2012166_CR45","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1172\/JCI28034","volume":"117","author":"JP Tuckermann","year":"2007","unstructured":"Tuckermann, J. P.  et al. Macrophages and neutrophils are the targets for immune suppression by glucocorticoids in contact allergy. J. Clin. Invest. 117, 1381\u20131390 (2007).","journal-title":"J. Clin. Invest."},{"key":"BFnrrheum2012166_CR46","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1096\/fj.11-192112","volume":"26","author":"A Kleiman","year":"2012","unstructured":"Kleiman, A.  et al. Glucocorticoid receptor dimerization is required for survival in septic shock via suppression of interleukin-1 in macrophages. FASEB J. 26, 722\u2013729 (2012).","journal-title":"FASEB J."},{"key":"BFnrrheum2012166_CR47","doi-asserted-by":"publisher","first-page":"3649","DOI":"10.1096\/fj.09-134684","volume":"23","author":"E Ayroldi","year":"2009","unstructured":"Ayroldi, E. & Riccardi, C. Glucocorticoid-induced leucine zipper (GILZ): a new important mediator of glucocorticoid action. FASEB J. 23, 3649\u20133658 (2009).","journal-title":"FASEB J."},{"key":"BFnrrheum2012166_CR48","doi-asserted-by":"publisher","first-page":"29603","DOI":"10.1074\/jbc.M101522200","volume":"276","author":"PR Mittelstadt","year":"2001","unstructured":"Mittelstadt, P. R. & Ashwell, J. D. Inhibition of AP-1 by the glucocorticoid-inducible protein GILZ. J. Biol. Chem. 276, 29603\u201329610 (2001).","journal-title":"J. Biol. Chem."},{"key":"BFnrrheum2012166_CR49","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1002\/art.27566","volume":"62","author":"E Beaulieu","year":"2010","unstructured":"Beaulieu, E.  et al. Glucocorticoid-induced leucine zipper is an endogenous anti-inflammatory mediator in arthritis. Arthritis Rheum. 62, 2651\u20132661 (2010).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2012166_CR50","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1084\/jem.20060336","volume":"203","author":"SM Abraham","year":"2006","unstructured":"Abraham, S. M.  et al. Anti-inflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase 1. J. Exp. Med. 203, 1883\u20131889 (2006).","journal-title":"J. Exp. Med."},{"key":"BFnrrheum2012166_CR51","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.1210\/me.2007-0067","volume":"21","author":"JV Maier","year":"2007","unstructured":"Maier, J. V.  et al. Dual specificity phosphatase 1 knockout mice show enhanced susceptibility to anaphylaxis but are sensitive to glucocorticoids. Mol. Endocrinol. 21, 2663\u20132671 (2007).","journal-title":"Mol. Endocrinol."},{"key":"BFnrrheum2012166_CR52","doi-asserted-by":"publisher","first-page":"4313","DOI":"10.1182\/blood-2006-10-048215","volume":"109","author":"S Bhattacharyya","year":"2007","unstructured":"Bhattacharyya, S., Brown, D. E., Brewer, J. A., Vogt, S. K. & Muglia, L. J. Macrophage glucocorticoid receptors regulate Toll-like receptor 4-mediated inflammatory responses by selective inhibition of p38 MAP kinase. Blood 109, 4313\u20134319 (2007).","journal-title":"Blood"},{"key":"BFnrrheum2012166_CR53","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1002\/art.34403","volume":"64","author":"Y Vattakuzhi","year":"2012","unstructured":"Vattakuzhi, Y., Abraham, S. M., Freidin, A., Clark, A. R. & Horwood, N. J. Dual specificity phosphatase 1 null mice exhibit spontaneous osteolytic disease and enhanced inflammatory osteolysis in experimental arthritis. Arthritis Rheum. 64, 2201\u20132210 (2012).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2012166_CR54","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/nri2470","volume":"9","author":"M Perretti","year":"2009","unstructured":"Perretti, M. & D'Acquisto, F. Annexin A1 and glucocorticoids as effectors of the resolution of inflammation. Nat. Rev. Immunol. 9, 62\u201370 (2009).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnrrheum2012166_CR55","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1002\/art.20201","volume":"50","author":"YH Yang","year":"2004","unstructured":"Yang, Y. H.  et al. Modulation of inflammation and response to dexamethasone by Annexin 1 in antigen-induced arthritis. Arthritis Rheum. 50, 976\u2013984 (2004).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2012166_CR56","doi-asserted-by":"crossref","unstructured":"Patel, H. B.  et al. The impact of endogenous annexin A1 on glucocorticoid control of inflammatory arthritis. Ann. Rheum. Dis. doi:10.1136\/annrheumdis-2011-201180.","DOI":"10.1136\/annrheumdis-2011-201180"},{"key":"BFnrrheum2012166_CR57","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/ar2107","volume":"9","author":"SK Lundy","year":"2007","unstructured":"Lundy, S. K., Sarkar, S., Tesmer, L. A. & Fox, D. A. Cells of the synovium in rheumatoid arthritis. T lymphocytes. Arthritis Res. Ther. 9, 202 (2007).","journal-title":"Arthritis Res. Ther."},{"key":"BFnrrheum2012166_CR58","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1056\/NEJMra1004965","volume":"365","author":"IB Mcinnes","year":"2011","unstructured":"Mcinnes, I. B. & Schett, G. The pathogenesis of rheumatoid arthritis. N. Engl. J. Med. 365, 2205\u20132219 (2011).","journal-title":"N. Engl. J. Med."},{"key":"BFnrrheum2012166_CR59","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1136\/ard.2007.076430","volume":"67","author":"M Hegen","year":"2008","unstructured":"Hegen, M., Keith, J. C. Jr, Collins, M. & Nickerson-Nutter, C. L. Utility of animal models for identification of potential therapeutics for rheumatoid arthritis. Ann. Rheum. Dis. 67, 1505\u20131515 (2008).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum2012166_CR60","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/S0092-8674(00)81989-3","volume":"87","author":"V Kouskoff","year":"1996","unstructured":"Kouskoff, V.  et al. Organ-specific disease provoked by systemic autoimmunity. Cell 87, 811\u2013822 (1996).","journal-title":"Cell"},{"key":"BFnrrheum2012166_CR61","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.4049\/jimmunol.169.2.1068","volume":"169","author":"R Fritsch","year":"2002","unstructured":"Fritsch, R.  et al. Characterization of autoreactive T cells to the autoantigens heterogeneous nuclear ribonucleoprotein A2 (RA33) and filaggrin in patients with rheumatoid arthritis. J. Immunol. 169, 1068\u20131076 (2002).","journal-title":"J. Immunol."},{"key":"BFnrrheum2012166_CR62","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/ar1478","volume":"7","author":"E Lubberts","year":"2005","unstructured":"Lubberts, E., Koenders, M. I. & van den Berg, W. B. The role of T-cell interleukin-17 in conducting destructive arthritis: lessons from animal models. Arthritis Res. Ther. 7, 29\u201337 (2005).","journal-title":"Arthritis Res. Ther."},{"key":"BFnrrheum2012166_CR63","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1084\/jem.20040165","volume":"200","author":"MR Ehrenstein","year":"2004","unstructured":"Ehrenstein, M. R.  et al. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNF\u03b1 therapy. J. Exp. Med. 200, 277\u2013285 (2004).","journal-title":"J. Exp. Med."},{"key":"BFnrrheum2012166_CR64","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.it.2011.06.007","volume":"32","author":"K Ghoreschi","year":"2011","unstructured":"Ghoreschi, K., Laurence, A., Yang, X. P., Hirahara, K. & O'Shea, J. J. T helper 17 cell heterogeneity and pathogenicity in autoimmune disease. Trends Immunol. 32, 395\u2013401 (2011).","journal-title":"Trends Immunol."},{"key":"BFnrrheum2012166_CR65","doi-asserted-by":"publisher","first-page":"7238","DOI":"10.4049\/jimmunol.0903841","volume":"184","author":"MM Zaiss","year":"2010","unstructured":"Zaiss, M. M.  et al. Regulatory T cells protect from local and systemic bone destruction in arthritis. J Immunol. 184, 7238\u20137246 (2010).","journal-title":"J Immunol."},{"key":"BFnrrheum2012166_CR66","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1182\/blood-2004-12-4790","volume":"106","author":"M L\u00f6wenberg","year":"2005","unstructured":"L\u00f6wenberg, M.  et al. Rapid immunosuppressive effects of glucocorticoids mediated through Lck and Fyn. Blood 106, 1703\u20131710 (2005).","journal-title":"Blood"},{"key":"BFnrrheum2012166_CR67","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1038\/sj.embor.7400775","volume":"7","author":"M L\u00f6wenberg","year":"2006","unstructured":"L\u00f6wenberg, M.  et al. Glucocorticoids cause rapid dissociation of a T cell-receptor-associated protein complex containing LCK and FYN. EMBO Rep. 7, 1023\u20131029 (2006).","journal-title":"EMBO Rep."},{"key":"BFnrrheum2012166_CR68","doi-asserted-by":"publisher","first-page":"7108","DOI":"10.1093\/emboj\/20.24.7108","volume":"20","author":"O Kassel","year":"2001","unstructured":"Kassel, O.  et al. Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP-1. EMBO J. 20, 7108\u20137116 (2001).","journal-title":"EMBO J."},{"key":"BFnrrheum2012166_CR69","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1182\/blood.V98.3.743","volume":"98","author":"E Ayroldi","year":"2001","unstructured":"Ayroldi, E. Modulation of T cell activation by the glucocorticoid-induced leucine zipper factor via inhibition of nuclear factor \u03baB. Blood 98, 743\u2013753 (2001).","journal-title":"Blood"},{"key":"BFnrrheum2012166_CR70","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1002\/art.25043","volume":"62","author":"EM Colin","year":"2010","unstructured":"Colin, E. M.  et al. 1,25-dihydroxyvitamin D3 modulates TH17 polarization and interleukin-22 expression by memory T cells from patients with early rheumatoid arthritis. Arthritis Rheum. 62, 132\u2013142 (2010).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2012166_CR71","doi-asserted-by":"publisher","first-page":"4089","DOI":"10.4049\/jimmunol.181.6.4089","volume":"181","author":"L McKinley","year":"2008","unstructured":"McKinley, L.  et al. TH17 cells mediate steroid-resistant airway inflammation and airway hyperresponsiveness in mice. J. Immunol. 181, 4089\u20134097 (2008).","journal-title":"J. Immunol."},{"key":"BFnrrheum2012166_CR72","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/ar2125","volume":"9","author":"C Mauri","year":"2007","unstructured":"Mauri, C. & Ehrenstein, M. R. Cells of the synovium in rheumatoid arthritis. B cells. Arthritis Res. Ther. 9, 205 (2007).","journal-title":"Arthritis Res. Ther."},{"key":"BFnrrheum2012166_CR73","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/j.1600-065X.1997.tb00958.x","volume":"156","author":"IC MacLennan","year":"1997","unstructured":"MacLennan, I. C.  et al. The changing preference of T and B cells for partners as T-dependent antibody responses develop. Immunol. Rev. 156, 53\u201366 (1997).","journal-title":"Immunol. Rev."},{"key":"BFnrrheum2012166_CR74","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1177\/153537020222700907","volume":"227","author":"D Lill-Elghanian","year":"2002","unstructured":"Lill-Elghanian, D., Schwartz, K., King, L. & Fraker, P. Glucocorticoid-induced apoptosis in early B cells from human bone marrow. Exp. Biol. Med. (Maywood) 227, 763\u2013770 (2002).","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"BFnrrheum2012166_CR75","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1093\/intimm\/dxh230","volume":"17","author":"H Igarashi","year":"2005","unstructured":"Igarashi, H.  et al. Early lymphoid progenitors in mouse and man are highly sensitive to glucocorticoids. Int. Immunol. 17, 501\u2013511 (2005).","journal-title":"Int. Immunol."},{"key":"BFnrrheum2012166_CR76","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1146\/annurev.immunol.25.022106.141702","volume":"25","author":"JN Arnold","year":"2007","unstructured":"Arnold, J. N., Wormald, M. R., Sim, R. B., Rudd, P. M. & Dwek, R. A. The impact of glycosylation on the biological function and structure of human immunoglobulins. Annu. Rev. Immunol. 25, 21\u201350 (2007).","journal-title":"Annu. Rev. Immunol."},{"key":"BFnrrheum2012166_CR77","doi-asserted-by":"publisher","first-page":"2818","DOI":"10.1002\/eji.1830251016","volume":"25","author":"M Moser","year":"1995","unstructured":"Moser, M.  et al. Glucocorticoids downregulate dendritic cell function in vitro and in vivo. Eur. J. Immunol. 25, 2818\u20132824 (1995).","journal-title":"Eur. J. Immunol."},{"key":"BFnrrheum2012166_CR78","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1002\/(SICI)1521-4141(200004)30:4<1233::AID-IMMU1233>3.0.CO;2-F","volume":"30","author":"MK Matyszak","year":"2000","unstructured":"Matyszak, M. K., Citterio, S., Rescigno, M. & Ricciardi-Castagnoli, P. Differential effects of corticosteroids during different stages of dendritic cell maturation. Eur. J. Immunol. 30, 1233\u20131242 (2000).","journal-title":"Eur. J. Immunol."},{"key":"BFnrrheum2012166_CR79","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1189\/jlb.1110615","volume":"91","author":"A Larang\u00e9","year":"2012","unstructured":"Larang\u00e9, A., Antonios, D., Pallardy, M. & Kerdine-R\u00f6mer, S. Glucocorticoids inhibit dendritic cell maturation induced by Toll-like receptor 7 and Toll-like receptor 8. J. Leukoc. Biol. 91, 105\u2013117 (2012).","journal-title":"J. Leukoc. Biol."},{"key":"BFnrrheum2012166_CR80","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1093\/intimm\/11.9.1519","volume":"11","author":"L Piemonti","year":"1999","unstructured":"Piemonti, L.  et al. Glucocorticoids increase the endocytic activity of human dendritic cells. Int. Immunol. 11, 1519\u20131526 (1999).","journal-title":"Int. Immunol."},{"key":"BFnrrheum2012166_CR81","doi-asserted-by":"publisher","first-page":"4995","DOI":"10.4049\/jimmunol.172.8.4995","volume":"172","author":"RE Wiley","year":"2004","unstructured":"Wiley, R. E.  et al. Transient corticosteroid treatment permanently amplifies the Th2 response in a murine model of asthma. J. Immunol. 172, 4995\u20135005 (2004).","journal-title":"J. Immunol."},{"key":"BFnrrheum2012166_CR82","doi-asserted-by":"publisher","first-page":"841","DOI":"10.4049\/jimmunol.0802046","volume":"183","author":"C Luther","year":"2009","unstructured":"Luther, C.  et al. Prednisolone treatment induces tolerogenic dendritic cells and a regulatory milieu in myasthenia gravis patients. J. Immunol. 183, 841\u2013848 (2009).","journal-title":"J. Immunol."},{"key":"BFnrrheum2012166_CR83","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.mce.2010.04.005","volume":"335","author":"AE Coutinho","year":"2011","unstructured":"Coutinho, A. E. & Chapman, K. E. The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights. Mol. Cell Endocrinol. 335, 2\u201313 (2011).","journal-title":"Mol. Cell Endocrinol."},{"key":"BFnrrheum2012166_CR84","doi-asserted-by":"publisher","first-page":"3783","DOI":"10.1002\/art.20664","volume":"50","author":"DM Gerlag","year":"2004","unstructured":"Gerlag, D. M.  et al. Effects of oral prednisolone on biomarkers in synovial tissue and clinical improvement in rheumatoid arthritis. Arthritis Rheum. 50, 3783\u20133791 (2004).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2012166_CR85","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1182\/blood-2006-02-001115","volume":"109","author":"J Ehrchen","year":"2007","unstructured":"Ehrchen, J.  et al. Glucocorticoids induce differentiation of a specifically activated, anti-inflammatory subtype of human monocytes. Blood 109, 1265\u20131274 (2007).","journal-title":"Blood"},{"key":"BFnrrheum2012166_CR86","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1136\/ard.2009.123422","volume":"69","author":"O Frey","year":"2010","unstructured":"Frey, O.  et al. Regulatory T cells control the transition from acute into chronic inflammation in glucose-6-phosphate isomerase-induced arthritis. Ann. Rheum. Dis. 69, 1511\u20131518 (2010).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum2012166_CR87","doi-asserted-by":"publisher","first-page":"3064","DOI":"10.1002\/eji.200526167","volume":"35","author":"S Solomon","year":"2005","unstructured":"Solomon, S., Rajasekaran, N., Jeisy-Walder, E., Snapper, S. B. & Illges, H. A crucial role for macrophages in the pathology of K\/B \u00d7 N serum-induced arthritis. Eur. J. Immunol. 35, 3064\u20133073 (2005).","journal-title":"Eur. J. Immunol."},{"key":"BFnrrheum2012166_CR88","doi-asserted-by":"publisher","first-page":"4310","DOI":"10.4049\/jimmunol.1101604","volume":"187","author":"N Schweingruber","year":"2011","unstructured":"Schweingruber, N.  et al. Liposomal encapsulation of glucocorticoids alters their mode of action in the treatment of experimental autoimmune encephalomyelitis. J. Immunol. 187, 4310\u20134318 (2011).","journal-title":"J. Immunol."},{"key":"BFnrrheum2012166_CR89","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/S0167-5699(97)01087-6","volume":"18","author":"SW Edwards","year":"1997","unstructured":"Edwards, S. W. & Hallett, M. B. Seeing the wood for the trees: the forgotten role of neutrophils in rheumatoid arthritis. Immunol. Today 18, 320\u2013324 (1997).","journal-title":"Immunol. Today"},{"key":"BFnrrheum2012166_CR90","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/j.1365-2567.2006.02424.x","volume":"119","author":"D Tanaka","year":"2006","unstructured":"Tanaka, D., Kagari, T., Doi, H. & Shimozato, T. Essential role of neutrophils in anti-type II collagen antibody and lipopolysaccharide-induced arthritis. Immunology 119, 195\u2013202 (2006).","journal-title":"Immunology"},{"key":"BFnrrheum2012166_CR91","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1126\/science.1073176","volume":"297","author":"DM Lee","year":"2002","unstructured":"Lee, D. M. Mast cells: a cellular link between autoantibodies and inflammatory arthritis. Science 297, 1689\u20131692 (2002).","journal-title":"Science"},{"key":"BFnrrheum2012166_CR92","doi-asserted-by":"publisher","first-page":"2797","DOI":"10.1084\/jem.20071391","volume":"204","author":"JS Zhou","year":"2007","unstructured":"Zhou, J. S., Xing, W., Friend, D. S., Austen, K. F. & Katz, H. R. Mast cell deficiency in KitW-sh mice does not impair antibody-mediated arthritis. J. Exp. Med. 204, 2797\u20132802 (2007).","journal-title":"J. Exp. Med."},{"key":"BFnrrheum2012166_CR93","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.immuni.2011.09.015","volume":"35","author":"TB Feyerabend","year":"2011","unstructured":"Feyerabend, T. B.  et al. Cre-mediated cell ablation contests mast cell contribution in models of antibody and T cell-mediated autoimmunity. Immunity 35, 832\u2013844 (2011).","journal-title":"Immunity"},{"key":"BFnrrheum2012166_CR94","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1002\/art.20468","volume":"50","author":"GS Firestein","year":"2004","unstructured":"Firestein, G. S. NF-\u03baB: holy grail for rheumatoid arthritis? Arthritis Rheum. 50, 2381\u20132386 (2004).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2012166_CR95","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/nri2094","volume":"7","author":"IB Mcinnes","year":"2007","unstructured":"Mcinnes, I. B. & Schett, G. Cytokines in the pathogenesis of rheumatoid arthritis. Nat. Rev. Immunol. 7, 429\u2013442 (2007).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnrrheum2012166_CR96","doi-asserted-by":"publisher","first-page":"3241","DOI":"10.1002\/art.24963","volume":"60","author":"V Gossye","year":"2009","unstructured":"Gossye, V.  et al. Differential mechanism of NF-\u03baB inhibition by two glucocorticoid receptor modulators in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum. 60, 3241\u20133250 (2009).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2012166_CR97","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.cyto.2005.05.009","volume":"31","author":"JF Van Offel","year":"2005","unstructured":"Van Offel, J. F.  et al. Influence of bisphosphonates on the production of pro-inflammatory cytokines by activated human articular chondrocytes. Cytokine 31, 298\u2013304 (2005).","journal-title":"Cytokine"},{"key":"BFnrrheum2012166_CR98","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1634\/stemcells.2005-0415","volume":"24","author":"A Derfoul","year":"2006","unstructured":"Derfoul, A., Perkins, G. L., Hall, D. J. & Tuan, R. S. Glucocorticoids promote chondrogenic differentiation of adult human mesenchymal stem cells by enhancing expression of cartilage extracellular matrix genes. Stem Cells 24, 1487\u20131495 (2006).","journal-title":"Stem Cells"},{"key":"BFnrrheum2012166_CR99","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1007\/s00198-007-0394-0","volume":"18","author":"E Canalis","year":"2007","unstructured":"Canalis, E., Mazziotti, G., Giustina, A. & Bilezikian, J. P. Glucocorticoid-induced osteoporosis: pathophysiology and therapy. Osteoporos. Int. 18, 1319\u20131328 (2007).","journal-title":"Osteoporos. Int."},{"key":"BFnrrheum2012166_CR100","doi-asserted-by":"publisher","first-page":"4382","DOI":"10.1210\/endo.140.10.7034","volume":"140","author":"LC Hofbauer","year":"1999","unstructured":"Hofbauer, L. C.  et al. Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis. Endocrinology 140, 4382\u20134389 (1999).","journal-title":"Endocrinology"},{"key":"BFnrrheum2012166_CR101","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1002\/art.24445","volume":"60","author":"LC Hofbauer","year":"2009","unstructured":"Hofbauer, L. C.  et al. Prevention of glucocorticoid-induced bone loss in mice by inhibition of RANKL. Arthritis Rheum. 60, 1427\u20131437 (2009).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2012166_CR102","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.cmet.2010.05.005","volume":"11","author":"A Rauch","year":"2010","unstructured":"Rauch, A.  et al. Glucocorticoids suppress bone formation by attenuating osteoblast differentiation via the monomeric glucocorticoid receptor. Cell Metab. 11, 517\u2013531 (2010).","journal-title":"Cell Metab."},{"key":"BFnrrheum2012166_CR103","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.bone.2011.06.013","volume":"49","author":"H Henneicke","year":"2011","unstructured":"Henneicke, H.  et al. Corticosterone selectively targets endo-cortical surfaces by an osteoblast-dependent mechanism. Bone 49, 733\u2013742 (2011).","journal-title":"Bone"},{"key":"BFnrrheum2012166_CR104","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1172\/JCI28084","volume":"116","author":"HJ Kim","year":"2006","unstructured":"Kim, H. J.  et al. Glucocorticoids suppress bone formation via the osteoclast. J. Clin. Invest. 116, 2152\u20132160 (2006).","journal-title":"J. Clin. Invest."},{"key":"BFnrrheum2012166_CR105","doi-asserted-by":"publisher","first-page":"5592","DOI":"10.1210\/en.2006-0459","volume":"147","author":"D Jia","year":"2006","unstructured":"Jia, D., O'brien, C. A., Stewart, S. A., Manolagas, S. C. & Weinstein, R. S. Glucocorticoids act directly on osteoclasts to increase their life span and reduce bone density. Endocrinology 147, 5592\u20135599 (2006).","journal-title":"Endocrinology"},{"key":"BFnrrheum2012166_CR106","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1172\/JCI2799","volume":"102","author":"RS Weinstein","year":"1998","unstructured":"Weinstein, R. S., Jilka, R. L., Parfitt, A. M. & Manolagas, S. C. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. J. Clin. Invest. 102, 274\u2013282 (1998).","journal-title":"J. Clin. Invest."},{"key":"BFnrrheum2012166_CR107","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1172\/JCI6800","volume":"104","author":"LI Plotkin","year":"1999","unstructured":"Plotkin, L. I.  et al. Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin. J. Clin. Invest. 104, 1363\u20131374 (1999).","journal-title":"J. Clin. Invest."},{"key":"BFnrrheum2012166_CR108","doi-asserted-by":"publisher","first-page":"24120","DOI":"10.1074\/jbc.M611435200","volume":"282","author":"LI Plotkin","year":"2007","unstructured":"Plotkin, L. I., Manolagas, S. C. & Bellido, T. Glucocorticoids induce osteocyte apoptosis by blocking focal adhesion kinase-mediated survival. Evidence for inside-out signaling leading to anoikis. J. Biol. Chem. 282, 24120\u201324130 (2007).","journal-title":"J. Biol. Chem."},{"key":"BFnrrheum2012166_CR109","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1359\/JBMR.051103","volume":"21","author":"NE Lane","year":"2006","unstructured":"Lane, N. E.  et al. Glucocorticoid-treated mice have localized changes in trabecular bone material properties and osteocyte lacunar size that are not observed in placebo-treated or estrogen-deficient mice. J. Bone Miner. Res. 21, 466\u2013476 (2006).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrrheum2012166_CR110","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1210\/en.2003-0990","volume":"145","author":"CA O'brien","year":"2004","unstructured":"O'brien, C. A.  et al. Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength. Endocrinology 145, 1835\u20131841 (2004).","journal-title":"Endocrinology"},{"key":"BFnrrheum2012166_CR111","doi-asserted-by":"publisher","first-page":"3366","DOI":"10.1096\/fj.11-182519","volume":"25","author":"J Jia","year":"2011","unstructured":"Jia, J.  et al. Glucocorticoid dose determines osteocyte cell fate. FASEB J. 25, 3366\u20133376 (2011).","journal-title":"FASEB J."},{"key":"BFnrrheum2012166_CR112","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1038\/nm.2448","volume":"17","author":"J Xiong","year":"2011","unstructured":"Xiong, J.  et al. Matrix-embedded cells control osteoclast formation. Nat. Med. 17, 1235\u20131241 (2011).","journal-title":"Nat. Med."},{"key":"BFnrrheum2012166_CR113","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1038\/nm.2452","volume":"17","author":"T Nakashima","year":"2011","unstructured":"Nakashima, T.  et al. Evidence for osteocyte regulation of bone homeostasis through RANKL expression. Nat. Med. 17, 1231\u20131234 (2011).","journal-title":"Nat. Med."},{"key":"BFnrrheum2012166_CR114","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1182\/blood-2008-03-145169","volume":"113","author":"JJ Pinzone","year":"2009","unstructured":"Pinzone, J. J.  et al. The role of Dickkopf-1 in bone development, homeostasis, and disease. Blood 113, 517\u2013525 (2009).","journal-title":"Blood"},{"key":"BFnrrheum2012166_CR115","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.1210\/me.2007-0153","volume":"21","author":"K Horsch","year":"2007","unstructured":"Horsch, K.  et al. Mitogen-activated protein kinase phosphatase 1\/dual specificity phosphatase 1 mediates glucocorticoid inhibition of osteoblast proliferation. Mol. Endocrinol. 21, 2929\u20132940 (2007).","journal-title":"Mol. Endocrinol."},{"key":"BFnrrheum2012166_CR116","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00223-011-9509-x","volume":"89","author":"MM Conradie","year":"2011","unstructured":"Conradie, M. M.  et al. MKP-1 knockout does not prevent glucocorticoid-induced bone disease in mice. Calcif. Tissue Int. 89, 221\u2013227 (2011).","journal-title":"Calcif. Tissue Int."},{"key":"BFnrrheum2012166_CR117","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1080\/08977190802277880","volume":"26","author":"CA Luppen","year":"2008","unstructured":"Luppen, C. A., Chandler, R. L., Noh, T., Mortlock, D. P. & Frenkel, B. BMP-2 vs BMP-4 expression and activity in glucocorticoid-arrested MC3T3-E1 osteoblasts: smad signaling, not alkaline phosphatase activity, predicts rescue of mineralization. Growth Factors 26, 226\u2013237 (2008).","journal-title":"Growth Factors"},{"key":"BFnrrheum2012166_CR118","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1096\/fj.10-173393","volume":"25","author":"A Rauch","year":"2011","unstructured":"Rauch, A.  et al. An anti-inflammatory selective glucocorticoid receptor modulator preserves osteoblast differentiation. FASEB J. 25, 1323\u20131332 (2011).","journal-title":"FASEB J."},{"key":"BFnrrheum2012166_CR119","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/bonekey.2012.26","volume":"9","author":"R Franceschi","year":"2012","unstructured":"Franceschi, R., Ge, C. & Li, Y. Osteoblasts: more than we thought. IBMS BoneKEY 9, 1\u20133 (2012).","journal-title":"IBMS BoneKEY"},{"key":"BFnrrheum2012166_CR120","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1038\/nm.2665","volume":"18","author":"M Guan","year":"2012","unstructured":"Guan, M.  et al. Directing mesenchymal stem cells to bone to augment bone formation and increase bone mass. Nat. Med. 18, 456\u2013462 (2012).","journal-title":"Nat. Med."},{"key":"BFnrrheum2012166_CR121","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1111\/j.1476-5381.2011.01574.x","volume":"165","author":"E Joanny","year":"2012","unstructured":"Joanny, E.  et al. Anti-inflammatory effects of selective glucocorticoid receptor modulators are partially dependent on up-regulation of dual specificity phosphatase 1. Br. J. Pharmacol. 165, 1124\u20131136 (2012).","journal-title":"Br. J. Pharmacol."},{"key":"BFnrrheum2012166_CR122","doi-asserted-by":"publisher","first-page":"2608","DOI":"10.4049\/jimmunol.180.4.2608","volume":"180","author":"P Dewint","year":"2008","unstructured":"Dewint, P.  et al. A plant-derived ligand favoring monomeric glucocorticoid receptor conformation with impaired transactivation potential attenuates collagen-induced arthritis. J. Immunol. 180, 2608\u20132615 (2008).","journal-title":"J. Immunol."},{"key":"BFnrrheum2012166_CR123","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1210\/en.2010-0456","volume":"152","author":"M Rauner","year":"2011","unstructured":"Rauner, M.  et al. Dissociation of osteogenic and immunological effects by the selective glucocorticoid receptor agonist, compound A, in human bone marrow stromal cells. Endocrinology 152, 103\u2013112 (2011).","journal-title":"Endocrinology"},{"key":"BFnrrheum2012166_CR124","doi-asserted-by":"publisher","unstructured":"Thiele, S.  et al. Selective glucocorticoid receptor modulation maintains bone mineral density in mice. J. Bone Miner. Res. \n                    http:\/\/dx.doi.org\/10.1002\/jbmr.1688\n                    \n                  .","DOI":"10.1002\/jbmr.1688"}],"container-title":["Nature Reviews Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrrheum.2012.166.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrrheum.2012.166","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrrheum.2012.166.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T04:30:19Z","timestamp":1684470619000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrrheum.2012.166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,9]]},"references-count":124,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["BFnrrheum2012166"],"URL":"https:\/\/doi.org\/10.1038\/nrrheum.2012.166","relation":{},"ISSN":["1759-4790","1759-4804"],"issn-type":[{"value":"1759-4790","type":"print"},{"value":"1759-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,9]]}}}